Actavis buys generic unit for $810M
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Actavis Group |
Alpharma |
Acquisition of generic drug unit |
The $810M deal narrows Alpharma's focus while boosting Actavis' presence in the US generics business. |
|
genOway |
IngenKO |
Acquisition of assets |
IngenKo's closing set up a deal that expands genOway's work in transgenesis, taking over a number of projects in the works. |